JPMorgan Chase & Co. Reduces Stock Position in National Health Investors, Inc. (NYSE:NHI)

JPMorgan Chase & Co. decreased its holdings in National Health Investors, Inc. (NYSE:NHIFree Report) by 5.5% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 149,896 shares of the real estate investment trust’s stock after selling 8,717 shares during the period. JPMorgan Chase & Co. owned about 0.33% of National Health Investors worth $12,600,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds have also made changes to their positions in the business. Assetmark Inc. increased its stake in National Health Investors by 27.8% in the 3rd quarter. Assetmark Inc. now owns 648 shares of the real estate investment trust’s stock worth $54,000 after buying an additional 141 shares during the period. Aviance Capital Partners LLC increased its position in shares of National Health Investors by 6.2% during the third quarter. Aviance Capital Partners LLC now owns 3,788 shares of the real estate investment trust’s stock worth $318,000 after acquiring an additional 221 shares during the period. Arizona State Retirement System raised its stake in shares of National Health Investors by 1.9% during the second quarter. Arizona State Retirement System now owns 12,152 shares of the real estate investment trust’s stock valued at $823,000 after acquiring an additional 222 shares in the last quarter. Tidal Investments LLC boosted its holdings in shares of National Health Investors by 3.9% in the third quarter. Tidal Investments LLC now owns 6,762 shares of the real estate investment trust’s stock valued at $568,000 after purchasing an additional 254 shares during the period. Finally, Quarry LP purchased a new stake in shares of National Health Investors in the third quarter valued at approximately $27,000. 62.51% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

A number of equities research analysts have weighed in on NHI shares. Bank of America started coverage on National Health Investors in a research report on Tuesday, September 24th. They set a “buy” rating and a $92.00 target price for the company. StockNews.com downgraded National Health Investors from a “buy” rating to a “hold” rating in a report on Tuesday, October 15th. Wells Fargo & Company lowered shares of National Health Investors from an “overweight” rating to an “equal weight” rating and upped their price objective for the stock from $81.00 to $86.00 in a research note on Tuesday, October 1st. Finally, Truist Financial cut their target price on shares of National Health Investors from $78.00 to $72.00 and set a “hold” rating on the stock in a research report on Monday, December 23rd. Three equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $75.33.

View Our Latest Stock Report on National Health Investors

National Health Investors Price Performance

Shares of NHI stock opened at $66.22 on Friday. The stock’s 50-day moving average is $73.62 and its 200 day moving average is $75.81. National Health Investors, Inc. has a 1-year low of $51.59 and a 1-year high of $86.13. The company has a debt-to-equity ratio of 0.92, a current ratio of 10.29 and a quick ratio of 10.29. The company has a market cap of $3.01 billion, a P/E ratio of 22.76, a PEG ratio of 4.86 and a beta of 1.06.

National Health Investors (NYSE:NHIGet Free Report) last released its quarterly earnings results on Tuesday, November 5th. The real estate investment trust reported $0.65 earnings per share for the quarter, missing analysts’ consensus estimates of $1.07 by ($0.42). The firm had revenue of $63.32 million during the quarter, compared to the consensus estimate of $67.93 million. National Health Investors had a net margin of 38.53% and a return on equity of 10.11%. The firm’s quarterly revenue was up 1.7% on a year-over-year basis. During the same quarter in the prior year, the business posted $1.08 earnings per share. Research analysts predict that National Health Investors, Inc. will post 4.42 earnings per share for the current fiscal year.

National Health Investors Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 29th. Stockholders of record on Tuesday, December 31st will be issued a dividend of $0.90 per share. The ex-dividend date of this dividend is Tuesday, December 31st. This represents a $3.60 annualized dividend and a dividend yield of 5.44%. National Health Investors’s dividend payout ratio is presently 123.71%.

National Health Investors Profile

(Free Report)

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.

Featured Articles

Institutional Ownership by Quarter for National Health Investors (NYSE:NHI)

Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.